Member Info for xviolet

Blimey 2 early to post!
sp. Numis not Numbs
and my maths wrong - Synairgen potentially more costly that Sotrovimab.

Costs:
Acc to Reuters - Paxlovid is about $600 a course
Sotrovimab $2,000

Synairgen price is unknown - but according to Syn bb posters who had notes from presentations and research notes by Numbs they had a figure of £2,000 a treatment. So Syn cheaper than Sot by about 25% on current exchange rate.

Thanks Doc

Partner's mother is in a care home in Japan. Load of residents tested positive. All given Sotrovimab plus something else (I can check if you really want to know) in IV as early stages intervention. All recovered! But interesting that some Govts are dishing out a $2K treatment.

Costs....
"The U.S. government has paid around $530 for a 5-day course of Paxlovid, $700 per five-day course of molnupiravir, and $2,100 for a course of sotrovimab - the lone available antibody treatment shown to work against the now dominant Omicron variant of the virus."

https://www.reuters.com/business/healthcare-pharmaceuticals/price-covid-treatments-pfizer-merck-gsk-align-with-patient-benefits-report-2022-02-03/

Been away for a bit. I think yesterday Topol on Twitter was asking about Paxlovid resistance. I see Joey has covered the point here as well (2 days ago).

Makes me want to ask 1 question - how much is a treatment of Syn? I don't know how I missed that figure - but do we have one? Or a range of estimates. Thanks.

anyone daring to add?
its cheap. is it reasonably priced for what it has become. any thoughts?

I had a feeling it might make it as an early stages treatment but Syn bb posters told me it was too expensive for early stages treatment. I will have to some research, I guess.

gas? pxen
gold? arizona metals.

nirvana..."its fun to lose..."
but....quite possibly not.

last few days. 650,000 shares kind of trades.
i thought they were sells. but they were matched by buys.
aren't they some kind of direct movement from mm to mm?
anyone understand them - been quite a few here the last few days.

sorry I missed this Stacey A interview re Strive
anyone have a link?
thanks

Should be a ‘smile’ not question marks.

Thanks Dai. I hadnt seen that. ??

can see why equinor is having a good year
john who used to post on Valetta is hot for PXEN (Italian gas, I think).

yeah. years for canada.
thanks.

i know everyone says that LSE data is useless but there seemed to be a few large sells last couple of days.
(if they were sells). Is it fair to say the RNS and tweets bolstered the sp so it was a good time to sell large chunks?
or was it all just part of the regular ebb and flow of buys, sells, confidence and punts?

those LNG terminals.
could they take gas from Canada?
fair bit of gas, I think, over there.

Small trades? Maybe school kids? But US ones? Drawn in by that knockout 13k of sales.

only real downside?
I could make some guesses. Could have poor sales figures. Or high costs re inflation.
Despite that I've bought a few. But not going all in.

innit still going?
quite a marathon there.

Last year GSK announced its 3Q results on 21st October.
Don't know if pipeline updated at same time.
Thats all I could find in the few seconds b4 I run for the bus!
Take care all.